The acute pancreatitis market size is projected to reach US$ 8,827.37 million by 2030 from US$ 5,649.77 million in 2022. The market is expected to register a CAGR of 5.7% during 2022–2030. Advancements in specific acute pancreatitis treatments are likely to serve as one of the key trends in the market.
Acute Pancreatitis Market Analysis
Several factors fuel the acute pancreatitis market growth, including the rising prevalence of diabetes, advances in diagnostic tools, and the development of novel treatment options. Obesity, consumption of alcohol, gallstones, and some medications have collectively contributed to a rise in the incidence of acute pancreatitis globally. Key market players invest in clinical trials, strategic alliances, and collaborations to strengthen their product portfolios and acquire a competitive advantage. The industry is being pushed by rising prevalence and demand for better treatment options. Ongoing research and development efforts and collaborative approaches are also expected to foster innovation and enhance outcomes for acute pancreatitis patients, thereby boosting the growth of the acute pancreatitis market during the forecast period.
Acute Pancreatitis Market Overview
A targeted novel treatment strategy that halts disease progression and improves patient outcomes is needed to address the current disease burden of acute and severe acute pancreatitis. An article published in the National Library of Medicine in February 2023 focuses on three major approaches to advance acute pancreatitis treatments—the clinical identification and application of new genetic information; newly identified serum biomarkers, i.e., fatty acid ethyl esters (FAEEs); and acceleration in timing of early nutrition feedings in acute pancreatitis. Such developments in specific treatment approaches would lead to new treatment options to enhance outcomes and improve the acute pancreatitis market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Acute Pancreatitis Market: Strategic Insights
CAGR (2022 - 2030)5.7%- Market Size 2022
US$ 5,649.77 Million - Market Size 2030
US$ 8,827.37 Million
Market Dynamics
- Rising Incidence of Diabetes
- Advancements in Specific Acute Pancreatitis Treatments
- Upsurge in Awareness Programs on Acute Pancreatitis
Key Players
- Abbott Laboratories
- GE HealthCare Technologies Inc
- Samsung Healthcare
- Koninklijke Philips NV
- Baxter International Inc
- Dynavax Technologies Corp
- Actim Oy
- Medtronic Plc
- Boston Scientific Corp
- Fresenius Kabi AG
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Offerings - Medications
- Diagnosis
- Others
Causes - Gallstones
- Alcoholism
- Genetic Disorders
- Infections
- Others
End User - Hospitals
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Acute Pancreatitis Market Drivers and Opportunities
Rising Incidence of Diabetes Following Acute Pancreatitis to Favor Market Growth
The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of the pancreas, which causes diabetes in patients suffering from acute pancreatitis. Pancreatogenic diabetes is increasingly being linked to exocrine disorders of the pancreas. As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5–10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases, while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the acute pancreatitis market.
Upsurge in Awareness Programs on Acute Pancreatitis
Several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. The National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) formed a collaborative network of 10 clinical centers and 1 data coordination center in 2020 to address several knowledge gaps regarding acute pancreatitis. The consortium is referred to as Type 1 Diabetes after Acute Pancreatitis Consortium (T1DAPC). Thus, awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to provide lucrative opportunities for companies in the acute pancreatitis market.
Acute Pancreatitis Market Report Segmentation Analysis
Key segments that contributed to the derivation of the acute pancreatitis market analysis are offerings, causes, and end user.
- Based on offerings, the acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest share of the market in 2022. The others segment is anticipated to register the highest CAGR during the forecast period.
- In terms of causes, the market is categorized into gallstones, alcoholism, genetic disorders, infections, and others. The gallstones segment held the largest share of the market in 2022 and is projected to register the fastest CAGR during the forecast period.
- Based on end user, the market is segmented into hospitals, diagnostic laboratories, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2022. The diagnostic laboratories segment is estimated to register the fastest CAGR during the forecast period.
Acute Pancreatitis Market Share Analysis by Geography
The geographic scope of the acute pancreatitis market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the acute pancreatitis market. The growth of the market in this region is attributed to a high incidence of risk factors such as obesity and consumption of alcohol, modern healthcare infrastructure, and strong government campaigns promoting early detection and treatment. According to the 2021 National Survey on Drug Use and Health, ~174.3 million people in the US aged 12 and above consumed alcohol in 2020. According to Medscape data, ~40–50 acute pancreatitis cases per 100,000 adults are registered in the US annually. Nearly 275,000 hospital admissions in the US are due to acute pancreatitis. In addition, the region also has several key market players, such as pharmaceutical corporations and medical device manufacturers, who are actively involved in research and development to create innovative new and novel products in the market, thereby supporting the market growth in the region. Further, Asia Pacific is projected to grow with the highest CAGR in the coming years.
Acute Pancreatitis Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 5,649.77 Million |
| Market Size by 2030 | US$ 8,827.37 Million |
| Global CAGR (2022 - 2030) | 5.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered | By Offerings
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Acute Pancreatitis Market News and Recent Developments
The acute pancreatitis market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the acute pancreatitis market are listed below:
- Arrivo BioVentures announced that the Food and Drug Administration (FDA) has granted its subsidiary, Panafina Inc., Fast Track designation for its investigational new drug, RABI-767, for the treatment of acute pancreatitis predicted to progress to severe disease. RABI-767 is an investigational small-molecule lipase inhibitor that is administered by endoscopic ultrasound-guided peripancreatic injection. RABI-767 is currently being evaluated in a phase 2a trial in patients predicted to develop severe acute pancreatitis. (Source: Arrivo BioVentures, Press Release, July 2024)
- CalciMedica Inc. announced that its collaborator, St. Jude Children's Research Hospital (SJCRH), presented data from the initial cohort of the Phase 1/2 CRSPA study of Auxora (zegocractin injectable emulsion) in asparaginase-induced pancreatic toxicity (AIPT) at the 65th Annual American Society of Hematology (ASH) Meeting & Exposition on December 2023, in San Diego, CA. (Source: CalciMedica Inc., Press Release, December 2023)
Acute Pancreatitis Market Report Coverage and Deliverables
The “Acute Pancreatitis Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- Acute pancreatitis market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Acute pancreatitis market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Acute pancreatitis market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the acute pancreatitis market
- Detailed company profiles
- Analisi storica (2 anni), anno base, previsione (7 anni) con CAGR
- Analisi PEST e SWOT
- Valore/volume delle dimensioni del mercato - Globale, regionale, nazionale
- Industria e panorama competitivo
- Set di dati Excel
- Visualization and 3D Rendering Software Market
- Skin Graft Market
- Small Internal Combustion Engine Market
- Electronic Toll Collection System Market
- Trade Promotion Management Software Market
- Underwater Connector Market
- Maritime Analytics Market
- Semiconductor Metrology and Inspection Market
- Electronic Data Interchange Market
- Sports Technology Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Domande frequenti
The estimated value of the acute pancreatitis market accounted for US$ 8,827.37 million in 2030.
The global acute pancreatitis market is estimated to register a CAGR of 5.7% during the forecast period 2022–2030.
North America region dominated the acute pancreatitis market in 2022.
The rise in pancreatic cancer cases due to acute pancreatitis and rising incidences of diabetes following acute pancreatitis are the most influential factors responsible for market growth.
Abbott Laboratories, GE HealthCare Technologies Inc, Samsung Healthcare, Koninklijke Philips NV, Baxter International Inc, Dynavax Technologies Corp, Actim Oy, Medtronic Plc, Boston Scientific Corp, and Fresenius Kabi AG are the market players in the acute pancreatitis market.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Acute Pancreatitis Market
- Abbott Laboratories
- GE HealthCare Technologies Inc
- Samsung Healthcare
- Koninklijke Philips NV
- Baxter International Inc
- Dynavax Technologies Corp
- Actim Oy
- Medtronic Plc
- Boston Scientific Corp
- Fresenius Kabi AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For